BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 2857608)

  • 1. Acute and chronic regulation of alpha 2-adrenoceptor number and function in man.
    Jones CR; Hamilton CA; Whyte KF; Elliott HL; Reid JL
    Clin Sci (Lond); 1985; 68 Suppl 10():129s-132s. PubMed ID: 2857608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Desensitization of platelet alpha 2-adrenoceptors after short term infusions of adrenoceptor agonist in man.
    Jones CR; Giembcyz M; Hamilton CA; Rodger IW; Whyte K; Deighton N; Elliott HL; Reid JL
    Clin Sci (Lond); 1986 Feb; 70(2):147-53. PubMed ID: 2869850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. alpha-Adrenoceptor regulation in vivo and in vitro in the rabbit.
    Hamilton CA; Jones CR; Reid JL
    Clin Sci (Lond); 1985; 68 Suppl 10():125s-128s. PubMed ID: 2857607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The primary wave of epinephrine-induced platelet aggregation represents alpha 2-adrenoceptor status.
    Mehta J; Mehta P; Krop I; Lawson D
    Thromb Res; 1988 Mar; 49(6):531-7. PubMed ID: 2838931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. O-Methylated and sulfoconjugated catecholamines: differential activities at human platelet alpha 2-adrenoceptors.
    Lenz T; Werle E; Strobel G; Weicker H
    Can J Physiol Pharmacol; 1991 Jul; 69(7):929-37. PubMed ID: 1683267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human platelet alpha 2-adrenoceptors: relationship between radioligand binding studies and adrenaline-induced aggregation in normal individuals.
    Swart SS; Pearson D; Wood JK; Barnett DB
    Eur J Pharmacol; 1984 Aug; 103(1-2):25-32. PubMed ID: 6090177
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of human platelet alpha 2-adrenoceptors with a new antagonist [3H]-RX821002, a 2-methoxy derivative of idazoxan.
    Galitzky J; Senard JM; Lafontan M; Stillings M; Montastruc JL; Berlan M
    Br J Pharmacol; 1990 Aug; 100(4):862-6. PubMed ID: 1976403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-adrenergic stimulation of phosphatidylinositol synthesis in human platelets as an alpha-2 effect secondary to platelet aggregation.
    Wallace MA; Agarwal KC; Garcia-Sainz JA; Fain JN
    J Cell Biochem; 1982; 18(2):213-20. PubMed ID: 6121823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time course of alpha 2-adrenoceptor desensitization induced by adrenaline infusion in man.
    Lübbecke F; Zschätzsch S; Mitrovic V; Husseini H; Schütterle G; Wizemann V
    Pharmacology; 1990; 40(4):231-5. PubMed ID: 2167486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of imidazoline and non-imidazoline alpha-adrenergic agents on canine platelet aggregation.
    Hikasa Y; Abe M; Satoh T; Hisashi Y; Ogasawara S; Matsuda H
    Pharmacology; 1999 Apr; 58(4):171-82. PubMed ID: 10077736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in rabbit platelet alpha and beta adrenoceptor number and platelet aggregation.
    Hamilton CA; Deighton NM; Jones CR; Reid JL
    Eur J Pharmacol; 1986 Oct; 130(1-2):145-9. PubMed ID: 3023112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mammalian platelet adrenoceptors.
    Kerry R; Scrutton MC; Wallis RB
    Br J Pharmacol; 1984 Jan; 81(1):91-102. PubMed ID: 6322894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased density and responsiveness of alpha 2 and beta-adrenoceptors in circulating blood cells of essential hypertensive patients.
    Brodde OE; Daul A; O'Hara N; Bock KD
    J Hypertens Suppl; 1984 Dec; 2(3):S111-4. PubMed ID: 6100731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variations in circulating catecholamines fail to alter human platelet alpha-2-adrenergic receptor number or affinity for [3H]yohimbine or [3H]dihydroergocryptine.
    Pfeifer MA; Ward K; Malpass T; Stratton J; Halter J; Evans M; Beiter H; Harker LA; Porte D
    J Clin Invest; 1984 Sep; 74(3):1063-72. PubMed ID: 6088579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Verapamil interacts in vitro with alpha 2-adrenoceptors but does not modify alpha 2-receptivity in vivo.
    Galinier M; Senard JM; Valet P; Boneu B; Galinier F; Montastruc JL
    Arch Int Pharmacodyn Ther; 1989; 301():30-9. PubMed ID: 2576196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid and reversible desensitisation of vascular and platelet alpha 2 adrenoceptors.
    Hamilton CA; Deighton NM; Reid JL
    Naunyn Schmiedebergs Arch Pharmacol; 1987 May; 335(5):534-40. PubMed ID: 2886922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet aggregation induced by alpha 2-adrenoceptor and protein kinase C activation. A novel synergism.
    Siess W; Lapetina EG
    Biochem J; 1989 Oct; 263(2):377-85. PubMed ID: 2574568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alpha 2-adrenoreceptor regulation in the human body].
    Robertson D; Onrot J; Biaggioni I; Hollister A
    Kardiologiia; 1986 Jan; 26(1):15-20. PubMed ID: 3005749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of imidazoline and non-imidazoline α-adrenergic agents on rabbit platelet aggregation.
    Yokota S; Hikasa Y; Mizushima H
    Pharmacology; 2013; 91(3-4):135-44. PubMed ID: 23364471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The in vitro effect of alpha-2 agonists on thrombocyte function and density of thrombocyte alpha-2 receptors].
    Heesen M; Dietrich GV; Detsch O; Drevermann J; Boldt J; Hempelmann G
    Anaesthesist; 1996 Mar; 45(3):255-8. PubMed ID: 8919899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.